Significance of molecular markers of prethrombotic state in liver cirrhosis patients with portal vein thrombosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200056263

Enrollment

Unknown

Registered

2022-02-03

Start date

2021-11-01

Completion date

Unknown

Last updated

2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver diseases

Interventions

PVT group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age>18 years; 2. Cirrhosis was diagnosed according to laboratory tests, ultrasound or radiology imaging results.

Exclusion criteria

Exclusion criteria: 1. With hepatocellular carcinoma or any other malignancy, 2. HIV-coinfections; 3. Patients with severe cardiac, respiratory, kidney disease or other severe diseases were also excluded.

Design outcomes

Primary

Measure	Time frame
Mortality;	—

Countries

China

Contacts

Public ContactJing Zhang

Beijing Youan Hospital, Capital Medical University

drzhangjing@163.com+8613391859683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026